KR20170000747A - 트러블 개선 및 피부 재생을 위한 용해성 미세바늘 패치 - Google Patents
트러블 개선 및 피부 재생을 위한 용해성 미세바늘 패치 Download PDFInfo
- Publication number
- KR20170000747A KR20170000747A KR1020150173491A KR20150173491A KR20170000747A KR 20170000747 A KR20170000747 A KR 20170000747A KR 1020150173491 A KR1020150173491 A KR 1020150173491A KR 20150173491 A KR20150173491 A KR 20150173491A KR 20170000747 A KR20170000747 A KR 20170000747A
- Authority
- KR
- South Korea
- Prior art keywords
- allantoin
- skin
- mixture
- sodium
- microneedles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000006872 improvement Effects 0.000 title description 10
- 230000036560 skin regeneration Effects 0.000 title description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 130
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 65
- 229960000458 allantoin Drugs 0.000 description 65
- ZFGMDIBRIDKWMY-PASTXAENSA-N heparin Chemical compound CC(O)=N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O[C@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@@H](O[C@@H]3[C@@H](OC(O)[C@H](OS(O)(=O)=O)[C@H]3O)C(O)=O)O[C@@H]2O)CS(O)(=O)=O)[C@H](O)[C@H]1O ZFGMDIBRIDKWMY-PASTXAENSA-N 0.000 description 62
- 210000003491 skin Anatomy 0.000 description 62
- 229940072113 onion extract Drugs 0.000 description 54
- 229920000669 heparin Polymers 0.000 description 52
- 239000000203 mixture Substances 0.000 description 42
- 229960001008 heparin sodium Drugs 0.000 description 38
- 230000000052 comparative effect Effects 0.000 description 16
- 241000234282 Allium Species 0.000 description 13
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 13
- 230000000694 effects Effects 0.000 description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- 206010040880 Skin irritation Diseases 0.000 description 11
- 238000000034 method Methods 0.000 description 11
- 231100000475 skin irritation Toxicity 0.000 description 11
- 230000036556 skin irritation Effects 0.000 description 11
- 239000000126 substance Substances 0.000 description 10
- 230000037303 wrinkles Effects 0.000 description 9
- 239000004480 active ingredient Substances 0.000 description 8
- 238000000605 extraction Methods 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 239000002537 cosmetic Substances 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 239000000284 extract Substances 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- 229960005150 glycerol Drugs 0.000 description 6
- 238000001953 recrystallisation Methods 0.000 description 6
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 5
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 5
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 5
- 239000006071 cream Substances 0.000 description 5
- 239000008213 purified water Substances 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 229940074410 trehalose Drugs 0.000 description 5
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 4
- 244000291564 Allium cepa Species 0.000 description 4
- 235000005255 Allium cepa Nutrition 0.000 description 4
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 4
- 206010015150 Erythema Diseases 0.000 description 4
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 4
- 239000001768 carboxy methyl cellulose Substances 0.000 description 4
- 238000002845 discoloration Methods 0.000 description 4
- 229920002674 hyaluronan Polymers 0.000 description 4
- 229960003160 hyaluronic acid Drugs 0.000 description 4
- 231100000241 scar Toxicity 0.000 description 4
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 4
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 4
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 3
- 241001094255 Elytraria Species 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 238000009792 diffusion process Methods 0.000 description 3
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 3
- 229940113120 dipropylene glycol Drugs 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 231100000321 erythema Toxicity 0.000 description 3
- 230000007803 itching Effects 0.000 description 3
- 235000019645 odor Nutrition 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
- 229960001631 carbomer Drugs 0.000 description 2
- 238000005266 casting Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 238000005470 impregnation Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- 230000000116 mitigating effect Effects 0.000 description 2
- 239000004014 plasticizer Substances 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 229920001059 synthetic polymer Polymers 0.000 description 2
- 229920003169 water-soluble polymer Polymers 0.000 description 2
- HOVAGTYPODGVJG-UVSYOFPXSA-N (3s,5r)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol Chemical compound COC1OC(CO)[C@@H](O)C(O)[C@H]1O HOVAGTYPODGVJG-UVSYOFPXSA-N 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- IUMSDRXLFWAGNT-UHFFFAOYSA-N Dodecamethylcyclohexasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 description 1
- IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical compound OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- DUFKCOQISQKSAV-UHFFFAOYSA-N Polypropylene glycol (m w 1,200-3,000) Chemical class CC(O)COC(C)CO DUFKCOQISQKSAV-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 241000270708 Testudinidae Species 0.000 description 1
- 239000002313 adhesive film Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 239000008309 hydrophilic cream Substances 0.000 description 1
- 238000003703 image analysis method Methods 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 210000001365 lymphatic vessel Anatomy 0.000 description 1
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 1
- -1 onion extract Chemical compound 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000003658 preventing hair loss Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000002195 soluble material Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 229960000281 trometamol Drugs 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0208—Tissues; Wipes; Patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Biomedical Technology (AREA)
- Materials Engineering (AREA)
- Alternative & Traditional Medicine (AREA)
- Molecular Biology (AREA)
- Anesthesiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Abstract
Description
도 1은 본 발명에 따른 미세바늘을 제조하는 여러 방법 중 일 예를 보여주는 도면이다.
도 2는 본 발명에 따른 미세바늘의 약물 방출 거동을 평가하기 위한 Franz diffusion cell을 나타낸다.
도 3은 본 발명에 따른 미세바늘의 주름 개선 효과를 나타낸 그래프이다. (붉은 그래프 : 실시예 1, 푸른 그래프 : 비교예 1)
성분 | 실시예 1 (단위: 중량%) |
oligo-HA | 6 |
Na-CMC | 6 |
Trehalose | 10 |
Glycerin | 5 |
디프로필렌글리콜 | 5 |
알란토인 | 0.5 |
양파추출물 | 5 |
헤파린나트륨 | 0.05 |
물 | To 100 |
원 료 명 | 비교예1 (단위: 중량%) |
|
1 | 세테아릴알코올 | 2.5 |
2 | 폴리글리세릴-3메칠글루코오스디스테아레이트 | 2.0 |
3 | 글리세릴스테아레이트 | 2 |
4 | 하이드로제네이티드폴리데센 | 5 |
5 | 사이클로헥사실록산 | 3 |
6 | 정제수 | To 100 |
7 | 글리세린 | 5 |
8 | 디프로필렌글라이콜 | 5 |
9 | 1,2-헥산디올 | 2 |
10 | 알란토인 | 0.5 |
11 | 헤파린나트륨 | 0.05 |
12 | 카보머 | 적량 |
13 | 폴리아크릴레이트크로스폴리머-6 | 0.5 |
14 | 잔탄검 | 0.3 |
15 | 트로메타민(10%) | 적량 |
16 | 양파 추출물 | 5 |
구분 | 30일 | |||
실온 | 40℃ | 50℃ | 0℃ | |
실시예 1 | 안정 | 안정 | 약변색, 약특이취 | 안정 |
비교예 1 | 변색 | 특이취 | 변색, 특이취 | 석출 |
구분 | 1일후 | 2일 후 | 4일 후 | 6일 후 | 8일 후 | 10일 후 | 12일 후 | 14일 후 |
실시예 1 | 0.04 | 0.00 | 0.08 | 0.08 | 0.08 | 0.10 | 0.10 | 0.08 |
비교예 1 | 0.04 | 0.10 | 0.14 | 0.30 | 0.28 | 0.26 | 0.24 | 0.26 |
돼지피부 및 acceptor solution내 함량 (ug/mL) | |||||
유효성분 | 6시간 | 12시간 | 18시간 | 24시간 | |
실시예 1 |
알란토인 | 12 | 15 | 17 | 20 |
헤파린나트륨 | 3 | 5 | 6 | 10 | |
비교예 1 |
알란토인 | 0.2 | 2 | 2 | 2.2 |
헤파린나트륨 | 0.1 | 0.15 | 0.15 | 0.2 |
구분 | 응답자 수 | |||
매우 우수 | 우수 | 미흡 | 매우 미흡 | |
실시예 1 | 11 | 16 | 3 | 0 |
비교예 1 | 2 | 5 | 14 | 9 |
Claims (11)
- 양파 추출물(Allium Cepa Ext.), 알란토인(Allantoin), 헤파린나트륨(Sodium Heparin) 또는 이들의 2 이상의 혼합물을 포함하는 용해성 미세바늘.
- 제1항에 있어서,
상기 미세바늘을 형성하는 물질은 피부 내에서 용해되는 것을 특징으로 하는 미세바늘. - 제2항에 있어서,
상기 미세바늘을 형성하는 물질은 히알루론산(Hyaluronic acid), 소듐-카르복시메틸 셀룰로오스, 소듐-카르복시메틸 셀룰로오스(Na-CMC, Sodium carboxymethyl cellulose), 비닐피롤리돈-비닐아세테이트 공중합체, 폴리비닐알코올(Poly vinyl alcohol), 폴리비닐피롤리돈(Poly vinyl pyrrolidone), 당류 또는 이들의 2 이상의 혼합물인 것을 특징으로 하는 미세바늘. - 제3항에 있어서,
상기 미세바늘은 미세바늘을 형성하는 물질 이외에 가소제(plasticizer)를 추가로 포함하는 것을 특징으로 하는 미세바늘. - 제1항에 있어서,
상기 양파 추출물은 정제수 및 에탄올의 혼합 용매 추출물인 것을 특징인 것으로 하는 미세바늘. - 제1항에 있어서,
상기 미세바늘은 미세바늘 총 중량 대비 양파 추출물 0.5 내지 10 중량%, 알란토인 0.01 내지 2 중량%, 헤파린나트륨 0.001 내지 0.5 중량% 또는 이들의 2 이상의 혼합물을 포함하는 것을 특징으로 하는 미세바늘. - 제1항에 있어서,
상기 미세바늘은 양파 추출물, 알란토인, 헤파린나트륨 또는 이들의 2 이상의 혼합물의 피부 투과량을 향상시키는 것을 특징으로 하는 미세바늘. - 제1항에 있어서,
상기 미세바늘은 피부 트러블 개선 또는 주름 개선 용도인 것을 특징으로 하는 미세바늘. - 제1항 내지 제8항 중 어느 한 항에 따른 미세바늘을 포함하는 미세바늘 패치.
- 양파 추출물, 알란토인, 헤파린나트륨 또는 이들의 2 이상의 혼합물 및 피부 내 용해성 물질을 혼합하는 단계를 포함하는 미세바늘의 제조 방법.
- 제1항 내지 제8항 중 어느 한 항에 따른 미세바늘을 이용하는 것을 특징으로 하는 양파 추출물, 알란토인, 헤파린나트륨 또는 이들의 2 이상의 혼합물을 피부 내로 전달하는 양파 추출물, 알란토인, 헤파린나트륨 또는 이들의 2 이상의 혼합물의 화장학적 피부 투여 방법.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20150090080 | 2015-06-24 | ||
KR1020150090080 | 2015-06-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20170000747A true KR20170000747A (ko) | 2017-01-03 |
KR102560150B1 KR102560150B1 (ko) | 2023-07-26 |
Family
ID=57797472
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020150173491A Active KR102560150B1 (ko) | 2015-06-24 | 2015-12-07 | 트러블 개선 및 피부 재생을 위한 용해성 미세바늘 패치 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102560150B1 (ko) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3792291A1 (en) | 2017-01-03 | 2021-03-17 | Lg Chem, Ltd. | Method for preparing modified conjugated diene-based polymer |
CN112999297A (zh) * | 2021-01-13 | 2021-06-22 | 上海行渝生物科技有限公司 | 用于瘢痕治疗的微针贴片及其制备方法 |
WO2021257018A1 (en) * | 2020-06-15 | 2021-12-23 | Montero Gida Sanayi Ve Ticaret Anonim Sirketi | Anti-scar and anti-aging topical compositions |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20050036076A (ko) * | 2003-10-15 | 2005-04-20 | 정용문 | 양파를 이용한 화장품 원료 제조방법 |
KR100844831B1 (ko) | 2007-02-16 | 2008-07-08 | 보람제약주식회사 | 알칼리 유화에 의해 안정화된 피부 외용제 및 그 제조방법 |
KR20130143288A (ko) * | 2012-06-21 | 2013-12-31 | 동성제약주식회사 | 흉터 치료용 피부외용제 조성물 |
KR20150011260A (ko) * | 2013-07-22 | 2015-01-30 | (주)아모레퍼시픽 | 패치 및 화장료 조성물을 포함하는 미용 키트 및 미용 방법 |
KR20150066829A (ko) * | 2013-12-09 | 2015-06-17 | 주식회사 엘지생활건강 | 마이크로니들용 조성물 |
-
2015
- 2015-12-07 KR KR1020150173491A patent/KR102560150B1/ko active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20050036076A (ko) * | 2003-10-15 | 2005-04-20 | 정용문 | 양파를 이용한 화장품 원료 제조방법 |
KR100844831B1 (ko) | 2007-02-16 | 2008-07-08 | 보람제약주식회사 | 알칼리 유화에 의해 안정화된 피부 외용제 및 그 제조방법 |
KR20130143288A (ko) * | 2012-06-21 | 2013-12-31 | 동성제약주식회사 | 흉터 치료용 피부외용제 조성물 |
KR20150011260A (ko) * | 2013-07-22 | 2015-01-30 | (주)아모레퍼시픽 | 패치 및 화장료 조성물을 포함하는 미용 키트 및 미용 방법 |
KR20150066829A (ko) * | 2013-12-09 | 2015-06-17 | 주식회사 엘지생활건강 | 마이크로니들용 조성물 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3792291A1 (en) | 2017-01-03 | 2021-03-17 | Lg Chem, Ltd. | Method for preparing modified conjugated diene-based polymer |
WO2021257018A1 (en) * | 2020-06-15 | 2021-12-23 | Montero Gida Sanayi Ve Ticaret Anonim Sirketi | Anti-scar and anti-aging topical compositions |
CN112999297A (zh) * | 2021-01-13 | 2021-06-22 | 上海行渝生物科技有限公司 | 用于瘢痕治疗的微针贴片及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
KR102560150B1 (ko) | 2023-07-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102493997B1 (ko) | 센텔라아시아티카를 함유한 용해성 마이크로니들 패치 | |
KR102009937B1 (ko) | 마이크로니들용 조성물 | |
KR20170000745A (ko) | 광감응물질 전달용 용해성 미세바늘 패치 | |
KR102517754B1 (ko) | 트라넥삼산 약물 전달용 용해성 미세바늘 패치 | |
KR102313517B1 (ko) | 난용성 약물 전달용 용해성 마이크로니들 | |
KR102451112B1 (ko) | 글루타치온 함유 용해성 미세바늘 패치 | |
KR102560150B1 (ko) | 트러블 개선 및 피부 재생을 위한 용해성 미세바늘 패치 | |
DE102009056746A1 (de) | Transdermales therapeutisches System für die Verabreichung von Peptiden | |
KR20170032801A (ko) | 아토피 피부염 치료제 전달을 위한 용해성 미세바늘 패치 | |
KR102493996B1 (ko) | 항염 효과의 성분을 포함하는 저자극 용해성 미세바늘 패치 | |
KR102313520B1 (ko) | 흡수 속도를 개선한 마이크로니들 시스템 | |
KR20170000750A (ko) | 디오스메틴 함유 마이크로니들 패치 | |
KR102399484B1 (ko) | 건선 치료제 전달을 위한 용해성 미세바늘 패치 | |
KR102594169B1 (ko) | 피부 미백 효과가 있는 알부틴 전달용 용해성 미세바늘 패치 | |
KR102525629B1 (ko) | 하이드록시산을 함유한 용해성 미세바늘 패치 | |
KR20170032808A (ko) | 멘톨 또는 멘톨 유도체를 포함하는 용해성 미세바늘 패치 | |
KR20170132570A (ko) | 탈모 방지제 및 발모 치료제 전달을 위한 용해성 미세바늘 패치 | |
KR20160145470A (ko) | 하이드로퀴논 전달용 용해성 미세바늘 패치 | |
KR102525628B1 (ko) | 알파―리포산 전달용 용해성 미세바늘 패치 | |
KR20170139964A (ko) | 타박상 치료제 전달을 위한 용해성 미세바늘 패치 | |
KR102493995B1 (ko) | 옥시레스베라트롤을 함유한 용해성 미세바늘 패치 | |
KR102560153B1 (ko) | 피부 볼륨 증진용 용해성 미세바늘 패치 | |
KR20170032813A (ko) | Hpv 백신 전달용 용해성 미세바늘 패치 | |
KR102203633B1 (ko) | 칼슘채널 차단제 전달용 용해성 미세바늘 | |
KR20170000740A (ko) | 리그닌퍼옥시다아제 전달용 용해성 미세바늘 패치 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20151207 |
|
PG1501 | Laying open of application | ||
A201 | Request for examination | ||
PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20201126 Comment text: Request for Examination of Application Patent event code: PA02011R01I Patent event date: 20151207 Comment text: Patent Application |
|
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20221110 Patent event code: PE09021S01D |
|
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20230531 Patent event code: PE09021S01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20230613 |
|
PG1601 | Publication of registration |